DTaP-IPV-HB-PRP~T

BIOLOGICAL3 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaHaemophilus Influenzae Type bHepatitis BPertussisPolioPoliomyelitisTetanus

Phase 2

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

CompletedNCT00831311

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Influenzae Type b, Pertussis +2

Start: 2004-10-31End: 2007-03-31Updated: 2013-12-17

Phase 3

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

CompletedNCT00313911

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2

Start: 2006-07-31End: 2008-02-29Updated: 2014-04-21

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

CompletedNCT00362336

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2

Start: 2006-08-31End: 2009-08-31Updated: 2014-05-02